Announcements Trials
Browse Landscape

Status

Completed 6Recruiting 2Enrolling by invitation 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Thoracic 1Endocrine 1CNS 1

Conditions

Breast Neoplasms 58Neoplasms 52Colorectal Neoplasms 32Prostatic Neoplasms 29Lung Neoplasms 21Stomach Neoplasms 17Carcinoma, Non-Small-Cell Lung 16Carcinoma, Hepatocellular 16Uterine Cervical Neoplasms 13Anxiety Disorders 13Colonic Neoplasms 11Brain Neoplasms 11Pancreatic Neoplasms 10Lymphoma, Follicular 9Leukemia, Myeloid, Acute 8Head and Neck Neoplasms 8Barrett Esophagus 8Urinary Bladder Neoplasms 7Rectal Neoplasms 7Esophageal Squamous Cell Carcinoma 7Esophageal Neoplasms 7Disease 7Diabetes Mellitus 7Cholangiocarcinoma 7Sarcoma 6Recurrence 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Pain 6Ovarian Neoplasms 6Motor Activity 6

Interventions

lorlatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × OTHER × Hyperlipidemias × Clear all
NCT07316075 2026-01-05

Multicenter Study on Cardiovascular and Metabolic Complications in Patients With Biochemically Silent Pheochromocytomas and Paragangliomas

Laikο General Hospital, Athens

Enrolling by invitation
50 enrolled
CNSEndocrine

Angina, Unstable, Cerebrovascular Disorders, Diabetes Mellitus, Hyperlipidemias, Myocarditis, Paraganglioma, Pericarditis, Pheochromocytoma, Cardiovascular Abnormalities

NCT06876675 2025-03-14

LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer

Peking University Third Hospital

Enrolling by invitation
167 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Hyperlipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡